INNPF Innocan Pharma Corp

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. InnoCan Pharma Corp market cap is $53.47M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. InnoCan Pharma Corp 52 week high is $0.3545 as of May 04, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. InnoCan Pharma Corp 52 week low is $0.143 as of May 04, 2024.

InnoCan Pharma Corp stock price today is $0.1995.

InnoCan Pharma Corp stock price yesterday was $0.2081.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. InnoCan Pharma Corp’s P/E ratio is -10.90.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. InnoCan Pharma Corp P/B ratio is 13.0307.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. InnoCan Pharma Corp's EBITDA is -15.73.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. InnoCan Pharma Corp 50-day moving average is $0.2196.

InnoCan Pharma Corp has 9 employees.